Protagenic Therapeutics, Inc. (PTIXW)
USD 0.01
(-42.86%)
USD 0.01
(-42.86%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -3.7 Million | -1.99 Million | -2.79 Million | -1.34 Million | -487.99 Thousand | -1.07 Million |
| Net Income | -5 Million | -3.55 Million | -4.52 Million | -2.54 Million | -1.75 Million | -2.55 Million |
| Depreciation & Amortization | 28.21 Thousand | 30.00 | 427.13 Thousand | 286.00 | 339.00 | 347.00 |
| Deferred income taxes | -723.26 Thousand | - | -427.13 Thousand | -248.55 Thousand | -348.29 Thousand | - |
| Stock-based compensation | 666.83 | 864.68 Thousand | 1.51 Million | 1.65 Million | 797.76 Thousand | 1.13 Million |
| Change in working capital | -114.41 Thousand | 540.13 Thousand | -140.38 Thousand | -361.43 Thousand | 702.2 Thousand | 109.73 Thousand |
| Other non-cash items | 1.43 Million | 156.84 Thousand | 345.95 Thousand | 154.89 Thousand | 110.91 Thousand | 246.19 Thousand |
| Investing Cash Flow | 4.77 Million | 1.59 Million | -9.9 Million | - | 250 Thousand | 1.04 Million |
| Investments in PPE | -149.77 Thousand | -1805.00 | - | - | - | - |
| Acquisitions | 630.31 Thousand | 46.05 Thousand | - | - | - | - |
| Investment purchases | -2.76 Million | -34.12 Thousand | -10.39 Million | - | - | -2.74 Million |
| Sales/Maturities of investments | 7.68 Million | 1.63 Million | 485.94 Thousand | - | 250 Thousand | 3.79 Million |
| Other Investing Activities | -630.31 Thousand | -46.05 Thousand | -9909.60 | - | 250.00 | 1045.66 |
| Financing Cash Flow | - | - | 12.57 Million | 1.22 Million | 670 Thousand | - |
| Debt repayment | - | - | -100 Thousand | -1.22 Million | -670 Thousand | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | 11.7 Million | - | - | - |
| Other Financing Activities | - | - | 969.62 Thousand | 2.44 Million | 1.34 Million | - |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | -27.32 Thousand | -91.59 Thousand | 340.12 Thousand | - | 99.54 Thousand | 98.58 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | -87.08 Thousand | 631.72 Thousand | -480.51 Thousand | -361.43 Thousand | 602.66 Thousand | 11.14 Thousand |
| Cash at beginning of period | 215.18 Thousand | 541.17 Thousand | 671.09 Thousand | 798.62 Thousand | 362.48 Thousand | 399.68 Thousand |
| Cash at end of period | 1.28 Million | 215.18 Thousand | 541.17 Thousand | 671.09 Thousand | 798.62 Thousand | 362.48 Thousand |
| Capital Expenditure | -149.77 Thousand | -1805.00 | - | - | - | - |
| Effect of forex changes on cash | 998.00 | 70.85 Thousand | 631.00 | -2163.00 | 4127.00 | -11.67 Thousand |
| Net cash flow / Change in cash | 1.07 Million | -325.98 Thousand | -129.92 Thousand | -127.53 Thousand | 436.13 Thousand | -37.2 Thousand |
| Free Cash Flow | -3.85 Million | -1.99 Million | -2.79 Million | -1.34 Million | -487.99 Thousand | -1.07 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -1.6 Million | -1.72 Million | -5 Million | -1.67 Million | -1.39 Million | -1.2 Million |
| Depreciation & Amortization | 12.57 Thousand | 12.57 Thousand | 28.21 Thousand | 26.61 Thousand | 1419.00 | 91.00 |
| Deferred income taxes | - | - | -723.26 Thousand | -219.94 Thousand | 23.17 Thousand | 118.94 Thousand |
| Stock-based compensation | 265.43 Thousand | 161.86 Thousand | 666.82 Thousand | 166.7 Thousand | 166.7 Thousand | 166.7 Thousand |
| Change in working capital | -171.83 Thousand | -109.12 Thousand | -114.41 Thousand | -176.57 Thousand | 545.1 Thousand | -633.07 Thousand |
| Other non-cash items | 239.04 Thousand | 186.8 Thousand | 1.43 Million | 734.94 Thousand | 4454.00 | 25.17 Thousand |
| Investing Cash Flow | 1.6 Million | 1.2 Million | 4.77 Million | 2.27 Million | 590.72 Thousand | 1.61 Million |
| Investments in PPE | - | - | -149.77 Thousand | -93.96 Thousand | -55.8 Thousand | - |
| Acquisitions | - | - | 630.31 Thousand | -2372.04 | 68.78 Thousand | - |
| Investment purchases | - | -297.12 Thousand | -2.76 Million | -2.75 Million | -12.97 Thousand | - |
| Sales/Maturities of investments | 1.6 Million | 1.5 Million | 7.68 Million | 5.12 Million | 659.5 Thousand | 1.61 Million |
| Other Investing Activities | 1.6 Million | 198.00 | -630.31 Thousand | 2372.04 | -68.78 Thousand | 1612.01 |
| Financing Cash Flow | 44.53 Thousand | - | - | 10.00 | -10.00 | - |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 44.53 Thousand | - | - | - | - | - |
| Other Financing Activities | 44.53 Thousand | - | - | 10.00 | - | - |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | - | -209.15 Thousand | -27.32 Thousand | -134.53 Thousand | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | -171.83 Thousand | -109.12 Thousand | -87.08 Thousand | -42.03 Thousand | 545.1 Thousand | -633.07 Thousand |
| Cash at beginning of period | 831.77 Thousand | 1.28 Million | 215.18 Thousand | 153.33 Thousand | 219.43 Thousand | 138.49 Thousand |
| Cash at end of period | 924.59 Thousand | 831.77 Thousand | 1.28 Million | 1.28 Million | 153.32 Thousand | 219.43 Thousand |
| Capital Expenditure | - | - | -149.77 Thousand | -93.96 Thousand | -55.8 Thousand | - |
| Effect of forex changes on cash | 167.00 | 190.00 | 998.00 | 920.00 | -1060.00 | 671.00 |
| Net cash flow / Change in cash | 92.81 Thousand | -456.11 Thousand | 1.07 Million | 1.13 Million | -66.11 Thousand | 80.94 Thousand |
| Free Cash Flow | -1.55 Million | -1.65 Million | -3.85 Million | -1.23 Million | -711.57 Thousand | -1.53 Million |
PARAS
VRFILMS
BAINF
002778
GWH-WT
OLGPF